FR2150559B1 - - Google Patents

Info

Publication number
FR2150559B1
FR2150559B1 FR7120905A FR7120905A FR2150559B1 FR 2150559 B1 FR2150559 B1 FR 2150559B1 FR 7120905 A FR7120905 A FR 7120905A FR 7120905 A FR7120905 A FR 7120905A FR 2150559 B1 FR2150559 B1 FR 2150559B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7120905A
Other languages
French (fr)
Other versions
FR2150559A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Priority to FR7120905A priority Critical patent/FR2150559A1/fr
Publication of FR2150559A1 publication Critical patent/FR2150559A1/fr
Application granted granted Critical
Publication of FR2150559B1 publication Critical patent/FR2150559B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
FR7120905A 1971-06-09 1971-06-09 Australia antigen purification - for preparation of purified suspensions Granted FR2150559A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7120905A FR2150559A1 (en) 1971-06-09 1971-06-09 Australia antigen purification - for preparation of purified suspensions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7120905A FR2150559A1 (en) 1971-06-09 1971-06-09 Australia antigen purification - for preparation of purified suspensions

Publications (2)

Publication Number Publication Date
FR2150559A1 FR2150559A1 (en) 1973-04-13
FR2150559B1 true FR2150559B1 (enrdf_load_stackoverflow) 1975-01-17

Family

ID=9078354

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7120905A Granted FR2150559A1 (en) 1971-06-09 1971-06-09 Australia antigen purification - for preparation of purified suspensions

Country Status (1)

Country Link
FR (1) FR2150559A1 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349539A (en) 1980-08-15 1982-09-14 Merck & Co., Inc. Separation of hepatitis B surface antigen

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349539A (en) 1980-08-15 1982-09-14 Merck & Co., Inc. Separation of hepatitis B surface antigen

Also Published As

Publication number Publication date
FR2150559A1 (en) 1973-04-13

Similar Documents

Publication Publication Date Title
ATA136472A (enrdf_load_stackoverflow)
AU2658571A (enrdf_load_stackoverflow)
AU2691671A (enrdf_load_stackoverflow)
AU2485671A (enrdf_load_stackoverflow)
AU3005371A (enrdf_load_stackoverflow)
AU2952271A (enrdf_load_stackoverflow)
AU2941471A (enrdf_load_stackoverflow)
AU2894671A (enrdf_load_stackoverflow)
AU2742671A (enrdf_load_stackoverflow)
AU2726271A (enrdf_load_stackoverflow)
AU2684071A (enrdf_load_stackoverflow)
AU2564071A (enrdf_load_stackoverflow)
AU2473671A (enrdf_load_stackoverflow)
AU2755871A (enrdf_load_stackoverflow)
AU2486471A (enrdf_load_stackoverflow)
AU3038671A (enrdf_load_stackoverflow)
AU2503871A (enrdf_load_stackoverflow)
AU3025871A (enrdf_load_stackoverflow)
AU2577671A (enrdf_load_stackoverflow)
AU2588771A (enrdf_load_stackoverflow)
AU2654071A (enrdf_load_stackoverflow)
AU2456871A (enrdf_load_stackoverflow)
AU2669471A (enrdf_load_stackoverflow)
AU2455871A (enrdf_load_stackoverflow)
AU2684171A (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
ST Notification of lapse